P. Leif Bergsagel

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression”.

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Journal of Clinical Oncology(2020)10.1200/jco.20.00437

N/A

5.1DataRank · unranked

182 citations

Romanos Sklavenitis‐Pistofidis, Jihye Park, Robert Redd, Benny Zhitomirsky, Andrew Dunford +31 more

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Journal of Clinical Oncology(2025)10.1200/jco-24-01893

N/A

2.3DataRank · unranked

151 citations

Faith E. Davies, Mehmet Samur, Jill Corre, Mattia D’Agostino, Martin Kaiser +41 more

Initial genome sequencing and analysis of multiple myeloma

Nature(2011)10.1038/nature09837

N/A

1.1DataRank · unranked

1438 citations

Michael S. Lawrence, Jonathan J. Keats, Kristian Cibulskis, Carrie Sougnez, Anna C. Schinzel +51 more

Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas

Blood(2023)10.1182/blood.2023021187

N/A

0.859DataRank · unranked

15 citations

Shaji Kumar, Linda B. Baughn, Angela Dispenzieri, Patricia T. Greipp, Rhett P. Ketterling +28 more

Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma

Cell Metabolism(2021)10.1016/j.cmet.2020.12.011

N/A

0.705DataRank · unranked

109 citations

Huan Liu, Jin He, Zhiqiang Wang, Zheng Yin, Gichun You +12 more

The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0005

N/A

0.546DataRank · unranked

37 citations

James B. Smadbeck, Nadine Abdallah, Cinthya Zepeda‐Mendoza, Moritz Binder, Kathryn E. Pearce +9 more

“Direct to Drug” screening as a precision medicine tool in multiple myeloma

Blood Cancer Journal(2020)10.1038/s41408-020-0320-7

N/A

0.489DataRank · unranked

25 citations

Nathalie Meurice, Joachim L. Petit, Alysia Polito, Yuan Xiao Zhu, Panwen Wang +19 more

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms

Blood Cancer Journal(2022)10.1038/s41408-022-00706-5

N/A

0.420DataRank · unranked

5 citations

Shulan Tian, Susan M. Geyer, Neeraj Sharma, Celine M. Vachon, Yael Kusne +7 more

Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma

Blood Cancer Journal(2023)10.1038/s41408-023-00851-5

N/A

0.360DataRank · unranked

10 citations

Erik Jessen, Neeraj Sharma, Hongwei Tang, James B. Smadbeck, Mark D. Long +13 more

The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias

Blood Cancer Journal(2020)10.1038/s41408-020-0294-5

N/A

0.312DataRank · unranked

7 citations

Zhuo Li, Kathryn E. Pearce, Celine M. Vachon, Mei‐Yin C. Polley, Jonathan J. Keats +10 more

Monosomic Loss of MIR15A/MIR16-1 Is a Driver of Multiple Myeloma Proliferation and Disease Progression

Blood Cancer Discovery(2020)10.1158/2643-3249.bcd-19-0068

N/A

0.165DataRank · unranked

2 citations

Caleb K. Stein, Victoria M. Garbitt, Meaghen E. Sharik, Yan W. Asmann, Matteo Bergsagel +7 more

CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.17.628799

N/A

0.165DataRank · unranked

2 citations

Linda B. Baughn, Mansour Poorebrahim, Alexandra M. Poos, Holly Lee, Marcella Kaddoura +24 more

Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.10.003

N/A

0.165DataRank · unranked

2 citations

Timothy T. Xu, Suheil Albert Atallah‐Yunes, Kenneth J C Lim, Sikander Ailawadhi, Ricardo Parrondo +17 more

Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)

Leukemia(2024)10.1038/s41375-024-02363-y

N/A

0.104DataRank · unranked

1 citations

Huihuang Yan, Suganti Shivaram, Stacey L. Lehman, Neeraj Sharma, James B. Smadbeck +21 more

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101214

N/A

0DataRank · unranked

17 citations

Fumou Sun, Daisy Alapat, Visanu Wanchai, David E. Mery, Wancheng Guo +24 more

Monosomic Loss of MIR15A/MIR16-1 Is a Driver of Multiple Myeloma Proliferation and Disease Progression

Blood Cancer Discovery(2020)10.1158/0008-5472.bcd-19-0068

N/A

0DataRank · unranked

39 citations

Caleb K. Stein, Victoria M. Garbitt, Meaghen E. Sharik, Yan W. Asmann, Matteo Bergsagel +7 more

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.027

N/A

0DataRank · unranked

3 citations

Nizar J. Bahlis, P. Leif Bergsagel, Manisha Bhutani, Niccolò Bolli, Carrie Brownstein +18 more

Disparity in the detection of chromosome 15 centromere in patients of African ancestry with a plasma cell neoplasm

Genetics in Medicine Open(2023)10.1016/j.gimo.2023.100816

N/A

0DataRank · unranked

2 citations

Hongwei Tang, Neeraj Sharma, Huihuang Yan, Shulan Tian, James B. Smadbeck +17 more

Molecular Pathogenesis of Multiple Myeloma

Hematology/Oncology Clinics of North America(2024)10.1016/j.hoc.2023.12.010

N/A

0DataRank · unranked

17 citations

P. Leif Bergsagel, Francesco Maura

Immunocompetent Mouse Models of Multiple Myeloma

Hematology/Oncology Clinics of North America(2024)10.1016/j.hoc.2023.12.014

N/A

0DataRank · unranked

3 citations

P. Leif Bergsagel, Marta Chesi, Megan T. Du

Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance

Blood Cancer Journal(2025)10.1038/s41408-025-01417-3

N/A

0DataRank · unranked

1 citations

Udit Yadav, Kishore Garapati, Kiran K. Mangalaparthi, Yogesh Chawla, Julia E. Wiedmeier +8 more

Expression of Nras Q61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice

Blood(2020)10.1182/blood.2020007156

N/A

0DataRank · unranked

44 citations

Adhithi Rajagopalan, Evan Flietner, Grant Yun, Marta Chesi, Quinlan Furumo +20 more

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

Nature Communications(2022)10.1038/s41467-022-30694-w

N/A

0DataRank · unranked

33 citations

Shankara Anand, Romanos Sklavenitis‐Pistofidis, Robert Redd, Eileen M. Boyle, Benny Zhitomirsky +22 more

Smoldering Multiple Myeloma

Hematology/Oncology Clinics of North America(2023)10.1016/j.hoc.2023.12.001

N/A

0DataRank · unranked

25 citations

P. Leif Bergsagel, Shaji Kumar, S. Vincent Rajkumar

Promiscuous Structural Variants Drive Myeloma Initiation and Progression

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-20-0170

N/A

0DataRank · unranked

5 citations

W. Michael Kuehl, P. Leif Bergsagel